Back to Index
Vivian Mo, MD
Clinical Associate Professor of Medicine (Clinician Educator)
HCC 322 Health Sciences Campus Los Angeles
+1 323 442 6130


Dr. Vivian Mo is an Assistant Professor of Clinical Medicine and specializes in cardiology and echocardiography. She completed her internship and residency in internal medicine and a fellowship in cardiology at the University of Texas - Southwestern Medical Center in Dallas. Currently she is the director of the Women's Cardiovascular Center of USC and is an active medical educator by serving as the associate program director of the cardiovascular medicine fellowship program.

While at USC, Dr. Mo has continued her research in the fields of preventive cardiology, echocardiography and cardiovascular disease in women. She currently serves as a co-investigator on a study which addresses carotid plaque composition by MRI while on statin therapy. She is also a site principal investigator for the VIRGO study which examines why outcomes of women differ from those of men in acute myocardial infarctions.

Dr. Mo is a fellow of the American College of Cardiology and the American Society of Echocardiography, and is a member of the American Heart Association.


Charles S. Houston Award

University of Texas- Southwestern Medical Center: Nomination for Outstanding Clinical Medicine Resident, 2003

Houston International Fund: Scholarship, 1996

Psi Chi Honor Society: Excellence in Psychology, 1996

LEXIA Scholarship


B-type natriuretic peptide, vascular endothelial growth factor, endothelin-1, and nitric oxide synthase in chronic mountain sickness. Am J Physiol Heart Circ Physiol. 2011 Apr; 300(4):H1427-33. View in: PubMed

High-sodium food choices by southern, urban African Americans with heart failure. J Card Fail. 2006 Mar; 12(2):144-8. View in: PubMed

The use of MCP-1 and soluble CD40 ligand in a pathophysiology-guided approach to the management of coronary artery disease. Future Cardiol. 2005 Sep; 1(5):649-56. View in: PubMed

Individualizing therapy in acute coronary syndromes: using a multiple biomarker approach for diagnosis, risk stratification, and guidance of therapy. Curr Cardiol Rep. 2004 Jul; 6(4):273-8. View in: PubMed

Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Implication for therapeutic decision making. Cancer. 2003 Aug 1; 98(3):508-15. View in: PubMed

Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer. 2003 Mar 15; 97(6):1464-70. View in: PubMed

Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer. 2001 Dec 15; 92(12):3030-6. View in: PubMed

Powered bySC CTSI